146 related articles for article (PubMed ID: 7594066)
1. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction.
Brand DA; Newcomer LN; Freiburger A; Tian H
J Am Coll Cardiol; 1995 Nov; 26(6):1432-6. PubMed ID: 7594066
[TBL] [Abstract][Full Text] [Related]
2. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM
Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
[TBL] [Abstract][Full Text] [Related]
4. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
Kramer JM; Hammill B; Anstrom KJ; Fetterolf D; Snyder R; Charde JP; Hoffman BS; Allen LaPointe N; Peterson E
Am Heart J; 2006 Sep; 152(3):454.e1-8. PubMed ID: 16923412
[TBL] [Abstract][Full Text] [Related]
5. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.
McLaughlin TJ; Soumerai SB; Willison DJ; Gurwitz JH; Borbas C; Guadagnoli E; McLaughlin B; Morris N; Cheng SC; Hauptman PJ; Antman E; Casey L; Asinger R; Gobel F
Arch Intern Med; 1996 Apr; 156(7):799-805. PubMed ID: 8615714
[TBL] [Abstract][Full Text] [Related]
6. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
[TBL] [Abstract][Full Text] [Related]
7. Beta blocker use in acute myocardial infarction in West Virginia.
Schade CP; Brehm JG; Stephens MK; Rezek G
W V Med J; 2002; 98(2):56-60. PubMed ID: 12048739
[TBL] [Abstract][Full Text] [Related]
8. Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population.
Fehrenbach SN; Budnitz DS; Gazmararian JA; Krumholz HM
Am J Manag Care; 2001 Jul; 7(7):717-23. PubMed ID: 11464429
[TBL] [Abstract][Full Text] [Related]
9. Prescribing of beta-blockers after myocardial infarction: a preliminary study of physician motivations and barriers.
Kavookjian J; Mamidi S
Clin Ther; 2008; 30 Pt 2():2241-9. PubMed ID: 19281918
[TBL] [Abstract][Full Text] [Related]
10. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Second Chinese Cardiac Study (CCS-2) Collaborative Group
J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
[TBL] [Abstract][Full Text] [Related]
11. Optimizing beta-blocker use after myocardial infarction.
Howard PA; Ellerbeck EF
Am Fam Physician; 2000 Oct; 62(8):1853-60, 1865-6. PubMed ID: 11057841
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of inappropriate prescribing of beta-blockers after an acute myocardial infarction in a Medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM; Bell D; Islam SS; Scott VG
Ann Pharmacother; 2005 Sep; 39(9):1416-22. PubMed ID: 15972326
[TBL] [Abstract][Full Text] [Related]
13. Beta-blocker use in patients with acute myocardial infarction treated by hospitalists.
Dall L; Simmons T; Peterson S; Herndon B
Manag Care Interface; 2000 May; 13(5):61-3, 69. PubMed ID: 11067397
[TBL] [Abstract][Full Text] [Related]
14. Study outlines key factors in successful beta-blocker use.
Rollins G
Rep Med Guidel Outcomes Res; 2001 Jun; 12(13):1-2, 5. PubMed ID: 12182170
[No Abstract] [Full Text] [Related]
15. The Cooperative Cardiovascular Project in Oklahoma.
Bratzler DW; de Leon AC; Johnson MC; Oehlert WH; Slagle RC; Murray CK; Bumpus LJ; Webb J
J Okla State Med Assoc; 1997; 90(6):219-27. PubMed ID: 9299892
[TBL] [Abstract][Full Text] [Related]
16. Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.
Rochon PA; Anderson GM; Tu JV; Clark JP; Gurwitz JH; Szalai JP; Lau P
CMAJ; 1999 Nov; 161(11):1403-8. PubMed ID: 10906894
[TBL] [Abstract][Full Text] [Related]
17. Lack of physician concordance with guidelines on the perioperative use of beta-blockers.
Siddiqui AK; Ahmed S; Delbeau H; Conner D; Mattana J
Arch Intern Med; 2004 Mar; 164(6):664-7. PubMed ID: 15037496
[TBL] [Abstract][Full Text] [Related]
18. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
[TBL] [Abstract][Full Text] [Related]
20. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction.
Ayanian JZ; Hauptman PJ; Guadagnoli E; Antman EM; Pashos CL; McNeil BJ
N Engl J Med; 1994 Oct; 331(17):1136-42. PubMed ID: 7935639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
